Diabetes is on the rise in children and young people

Published Date: 10 Mar 2023

New findings from researchers at Wake Forest University School of Medicine show that the rate of type 1 and type 2 diabetes is increasing...

Read Full News

Latest News

Pentagon Revives Testosterone Testing After Pause, Excludes Women

The Pentagon is reinstituting a mandatory testing program for testosterone deficiency among US service members age 30 and older, a spokesperson ⁠said on Thursday, bringing...

Osteoporosis: Are Bone Density Targets Worth Chasing?

Specialists debate the value of specific bone density goals with concerns that measurement variability and limited trial evidence may complicate treatment decisions.

GLP-1 Systematic Review Finds Weight Loss of Up to 24%

GLP-1 drugs are associated with substantial weight loss in adults without diabetes, and the range of options, including oral and multiagonist therapies, is expanding.

Nurse-Led Digital Therapeutics Boosts Diabetes Outcomes

A structured nurse-led digital therapeutics pathway is linked to higher adherence and more favorable metabolic outcomes than usual care in adults with type 2 diabetes, a study reports.

FDA Approves Generic Lutathera for Adults With GEP-NETs

Bexlutry is the first radioligand equivalent approved by the agency for treatment of the rare tumors.

Could Psilocybin Prevent Nerve Damage From Chemotherapy?

Preclinical findings suggest that psilocybin may protect sensory nerves from chemotherapy toxicity, but clinical trials are still needed to determine whether it benefits patients.

Todays Updates

Genetic Testing and Breast Cancer: Applying Guidelines and Clinical Evidence to the Identification and Management of Patients With Germline BRCA-Mutated Disease

Genetic Testing and Breast Cancer: Applying Guidelines and Clinical Evidence to the Identification and Management of Patients With Germline BRCA-Mutated Disease

Decrypting ADC Targets in PROC: Biomarker Expression, Testing, and Clinical Interpretation

Decrypting ADC Targets in PROC: Biomarker Expression, Testing, and Clinical Interpretation

Optimizing Use of Genetic Testing and Management of Care for Patients With Germline BRCA-Mutated Breast Cancer

Optimizing Use of Genetic Testing and Management of Care for Patients With Germline BRCA-Mutated Breast Cancer

FDA Expands Label of Oral HIV Drug to Newborns

Dolutegravir is already approved as combination therapy in adults and older children

Postpartum Psychosis: Who Is Most at Risk?

Disease has a continuum of severity, perinatal psychiatrist explains

U.S. Women Increasingly Not Screened for Cervical Cancer

Nearly one-third of women ages 21 to 29 had never undergone screening

These Women Face Higher Risk for Anal Sphincter Tears During Birth

Lifelong pelvic floor issues, such as incontinence, often ensue

Todays Updates

Genetic Testing and Breast Cancer: Applying Guidelines and Clinical Evidence to the Identification and Management of Patients With Germline BRCA-Mutated Disease

Genetic Testing and Breast Cancer: Applying Guidelines and Clinical Evidence to the Identification and Management of Patients With Germline BRCA-Mutated Disease

Decrypting ADC Targets in PROC: Biomarker Expression, Testing, and Clinical Interpretation

Decrypting ADC Targets in PROC: Biomarker Expression, Testing, and Clinical Interpretation

Optimizing Use of Genetic Testing and Management of Care for Patients With Germline BRCA-Mutated Breast Cancer

Optimizing Use of Genetic Testing and Management of Care for Patients With Germline BRCA-Mutated Breast Cancer

FDA Expands Label of Oral HIV Drug to Newborns

Dolutegravir is already approved as combination therapy in adults and older children

Postpartum Psychosis: Who Is Most at Risk?

Disease has a continuum of severity, perinatal psychiatrist explains

U.S. Women Increasingly Not Screened for Cervical Cancer

Nearly one-third of women ages 21 to 29 had never undergone screening

These Women Face Higher Risk for Anal Sphincter Tears During Birth

Lifelong pelvic floor issues, such as incontinence, often ensue

Latest News

The Pentagon is reinstituting a mandatory testing program for testosterone deficiency among US service members age 30 and older, a spokesperson ⁠said on Thursday, bringing...

Specialists debate the value of specific bone density goals with concerns that measurement variability and limited trial evidence may complicate treatment decisions.

GLP-1 drugs are associated with substantial weight loss in adults without diabetes, and the range of options, including oral and multiagonist therapies, is expanding.

A structured nurse-led digital therapeutics pathway is linked to higher adherence and more favorable metabolic outcomes than usual care in adults with type 2 diabetes, a study reports.

Bexlutry is the first radioligand equivalent approved by the agency for treatment of the rare tumors.

Preclinical findings suggest that psilocybin may protect sensory nerves from chemotherapy toxicity, but clinical trials are still needed to determine whether it benefits patients.

News All Time

Experts Urge FDA to Set Clear Safety and Access Standards for Psychedelic Drugs

Doctors, veterans, pharmacists and therapists on Monday urged the U.S. Food and Drug Administration to establish clear safety and access standards for psychedelic therapies...

Lilly Says Foundayo Has Captured Over 30% Of New US patients on Oral Weight-loss Drugs

Eli Lilly on Monday said it has captured more than 30% of new patients in the U.S. market for ⁠oral obesity treatments, narrowing the early lead gained by Danish rival Novo...

Obesity Runs in the Family. Here’s How to Stop It

Epigenetic transgenerational inheritance influences future generations. With continued exposure, the susceptibility to obesity and its associated comorbidities will threaten future generations.

Testosterone Scripts for Women Rise, Along With Denials and Delays

Women increasingly turning to testosterone therapy to manage menopause symptoms are running into unexpected prescription delays and denials at pharmacies, according to...

Food Tracking for Weight Loss: More Tracking, More Loss

In a study of 5132 app users, higher food tracking frequency was associated with greater weight loss, with more than 70% losing at least 5% of their body weight at 6 months.

Dysesthesia Risk Appears to Rise With GLP-1s

A meta-analysis suggests that GLP-1 drugs may raise the risk for dysesthesia, with greater weight loss potentially linked to a higher risk.

Thyroid, Other Autoimmune Issues Tied to Fertility Decline

Women with thyroid autoimmunity plus other autoimmune conditions have a nearly 6% rate of premature ovarian insufficiency, which is fivefold higher than that of those without autoimmune disorders.

FDA Clears New Type of Insulin Patch Pump From Beta Bionics

The company anticipates its two pumps will work with a next-generation insulin dosing algorithm.

Endocrine Society Launches New Initiatives Around Obesity

A new scientific statement was published and Center on Obesity was launched simultaneously.

New Guidance Addresses Diabetes and Smoking Cessation

The issue is underemphasized in clinical diabetes care, authors say.

Retatrutide: It’s Already in Your Waiting Room

Social media has triggered a retatrutide tsunami. What can clinicians do when patients disclose taking an unapproved weight-loss drug?

Whole-Plant Extract Outperforms THC on Glycemia

Whole-plant cannabis extract beats THC alone at improving glucose control in obese mice. Here's what the science means for patient conversations.

Novo Nordisk Says Wegovy Approved in China for MASH

Denmark's Novo Nordisk ⁠said on Thursday its blockbuster ⁠weight-loss drug Wegovy had ⁠been approved ‌in China as the first GLP-1 RA class of drugs for the ‌treatment of MASH.

High Semaglutide Dropout Rates Signal Adherence Challenge

With nearly half of patients discontinuing semaglutide within 12 months — especially younger adults — clinicians face a growing challenge in sustaining long-term treatment.

Weekly Basal Insulin + Semaglutide Combo May Benefit T2D

Novo Nordisk’s phase 3b trial shows once-weekly IcoSema improves glycemic control and weight with less hypoglycemia than insulin glargine U100 in adults with type 2 diabetes.

Menopausal Symptoms Worse in Women With Type 2 Diabetes

An observational study finds a higher number of symptoms and greater severity among midlife women with type 2 diabetes than among those without.

Recommended News For You

New Data Put ADCs on the Map in Relapsed SCLC

For the treatment of paroxysmal nocturnal hemoglobinuria, the FDA has approved an oral factor B inhibitor.

Cancer research in the US is world class. With the government pulling out, its future is uncertain

Researchers identify a novel biomarker linked to renal cancer recurrence

From Pathology to Precision: The Story of Leukemia Therapy

Disparities in use of MRI to detect prostate cancer: Race and location may influence testing

Increased anti-tumor response and reduced side effects from immune checkpoint inhibitors.

Recommended Articles For You

The Benefits and Side Effects of Bortezomib in the Fight Against Cancer  

Patient-Derived Response Maps for Therapy Selection: A Scientific Review 

Spatial Pharmacology Within the Tumor Microenvironment: Precision in Oncologic Therapeutics 

Hematopoietic Immune Microenvironment Plasticity: Mechanisms, Clinical Implications, and Emerging Therapeutics 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Pancreatic cancer RNA vaccine shows durable T cell immunity

2.

Dostarlimab Boosts Long-Term Survival in Endometrial Cancer

3.

Exercise can counter detrimental effects of cancer treatment, review suggests

4.

In patients with advanced lung cancer, cemiplimab combined with chemotherapy extends life and enhances quality of life.

5.

Survivors of high-risk neuroblastoma face substantial late effects of modern therapies

1.

Breaking Down the Benefits and Risks of Hematopoietic Stem Cell Transplantation 

2.

Targeting Oncology: Expanding Combinatorial Strategies by 2025

3.

Megakaryocyte Immune Cell Crosstalk: Mechanisms, Clinical Insights, and Therapeutic Implications

4.

How AI, Multi-Omics, and Real-World Evidence are Redefining Oncology Research and Shaping Cancer Care?

5.

From Bench to Bedside: The New Era of Lymphoma Treatment and Education

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

2.

Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL

3.

Understanding Blood Clotting Disorders

4.

Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC

5.

Current Cancer Scenario in India- Importance of Genomic Testing & Advancement in Diagnosis and Treatment

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot